post-anesthesia shivering.
Conditions
Interventions
Intervention 1: 0.2 milligram clonidine tablet will be administered to intervention group before the anesthesia. Intervention 2: Placebo tablet will be administered to control group before the anesthe
Treatment - Drugs
0.2 milligram clonidine tablet will be administered to intervention group before the anesthesia.
Placebo tablet will be administered to control group before the anesthesia.
Sponsors
Tehran University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
16 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 16-80 years, A.S.A I-II, elective surgery, Exclusion criteria: Hypotension (B.P. 140/95 mmHg), cardiac, renal or liver disease, addiction, previous clonidine usage, pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shivering. Timepoint: End of Anesthesia (Recovery room). Method of measurement: Crossley & Mahajan shivering score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean blood pressure. Timepoint: During operation. Method of measurement: sphygmomanometer.;SpO2. Timepoint: During operation. Method of measurement: Pulse oximtry.;Heart rate. Timepoint: During operation. Method of measurement: Cardiac monitoring.;Emergence from anesthesia. Timepoint: At the end of anesthesia. Method of measurement: Time (minute) emergence from anesthesia. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarsad Imani, Anesthesiologist, Assistant Professor
Tehran University of Medical Sciences, Anesthesia Group
Outcome results
None listed